SODIUM 4-((3-(2,6-DIMETHYLPHENYL)DIAZENYL)-2,4-DIHYDROXYPHENYL)DIAZENYL)BENZENESULFONATE
UNII 16U925M3DJ
Substance Identification & Data
This profile provides standardized clinical and technical data for Sodium 4-((3-(2,6-dimethylphenyl)diazenyl)-2,4-dihydroxyphenyl)diazenyl)benzenesulfonate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 16U925M3DJ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H17N4O5S.Na NXRUWBZEGPUXQT-HQHRKKNHSA-M Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Sodium 4-((3-(2,6-dimethylphenyl)diazenyl)-2,4-dihydroxyphenyl)diazenyl)benzenesulfonate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.